Cargando…

Exosome mediated miR-155 delivery confers cisplatin chemoresistance in oral cancer cells via epithelial-mesenchymal transition

Cisplatin is used as chemotherapeutic drug for oral squamous cell carcinoma (OSCC). However, OSCC cells develop resistance following long-term cisplatin exposure. Resistance against cisplatin chemo-therapy is accredited to the process of epithelial-to-mesenchymal transition, which in-turn has been l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kirave, Prathibha, Gondaliya, Piyush, Kulkarni, Bhagyashri, Rawal, Rakesh, Garg, Rachana, Jain, Alok, Kalia, Kiran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138164/ https://www.ncbi.nlm.nih.gov/pubmed/32284792 http://dx.doi.org/10.18632/oncotarget.27531

Ejemplares similares

Exosome-mediated delivery of miR-30a sensitize cisplatin-resistant variant of oral squamous carcinoma cells via modulating Beclin1 and Bcl2
por: Kulkarni, Bhagyashri, et al.
Publicado: (2020)

Method and its Composition for encapsulation, stabilization, and delivery of siRNA in Anionic polymeric nanoplex: An In vitro- In vivo Assessment
por: Raval, Nidhi, et al.
Publicado: (2019)

Correction: miR29b regulates aberrant methylation in In-Vitro diabetic nephropathy model of renal proximal tubular cells
por: Gondaliya, Piyush, et al.
Publicado: (2019)

miR29b regulates aberrant methylation in In-Vitro diabetic nephropathy model of renal proximal tubular cells
por: Gondaliya, Piyush, et al.
Publicado: (2018)

Exosome-mediated breast cancer chemoresistance via miR-155 transfer
por: Santos, Juliana Carvalho, et al.
Publicado: (2018)

MicroRNA-155 increases colon cancer chemoresistance to cisplatin by targeting forkhead box O3
por: Gao, Yuewen, et al.
Publicado: (2018)

Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK
por: Patel, Girijesh Kumar, et al.
Publicado: (2017)

Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer
por: Zhang, Qiumo, et al.
Publicado: (2020)

Exosome-Reversed Chemoresistance to Cisplatin in Non-Small Lung Cancer Through Transferring miR-613
por: Li, Delong, et al.
Publicado: (2020)

Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer [Corrigendum]
Publicado: (2022)

SMYD3 confers cisplatin chemoresistance of NSCLC cells in an ANKHD1-dependent manner
por: Lv, Hong-Wei, et al.
Publicado: (2021)

Cisplatin for cancer therapy and overcoming chemoresistance
por: Ranasinghe, Ranmali, et al.
Publicado: (2022)

Novel extracellular RNA biomarkers for early stage hepatocellular cancer
por: Gondaliya, Piyush, et al.
Publicado: (2021)

The Emerging Role of Exosomes in Cancer Chemoresistance
por: Li, Jing, et al.
Publicado: (2021)

Exosomes and their roles in the chemoresistance of pancreatic cancer
por: Pan, Yubin, et al.
Publicado: (2022)

Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma
por: Zhang, Kun, et al.
Publicado: (2020)

Paclitaxel-resistant gastric cancer MGC-803 cells promote epithelial-to-mesenchymal transition and chemoresistance in paclitaxel-sensitive cells via exosomal delivery of miR-155-5p
por: Wang, Mei, et al.
Publicado: (2018)

Retraction: Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma
Publicado: (2022)

Cancer-associated fibroblasts-derived exosomes from chemoresistant patients regulate cisplatin resistance and angiogenesis by delivering VEGFA in colorectal cancer
por: Shi, Yuanyuan, et al.
Publicado: (2022)

Tunneling Nanotube-Mediated Communication: A Mechanism of Intercellular Nucleic Acid Transfer
por: Driscoll, Julia, et al.
Publicado: (2022)

Characterization of etoposide- and cisplatin-chemoresistant retinoblastoma cell lines
por: Busch, Maike, et al.
Publicado: (2018)

TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma
por: Li, Cuiyun, et al.
Publicado: (2018)

BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma
por: Gao, Wei, et al.
Publicado: (2017)

Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma
por: Rodrigo, Miguel Angel Merlos, et al.
Publicado: (2021)

THU549 Targeting The Growth Hormone Receptor Attenuates Tumor Exosome Mediated Propagation Of Chemoresistance In Melanoma
por: Kulkarni, Prateek, et al.
Publicado: (2023)

Expression of Concern: Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma
Publicado: (2022)

The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance
por: Asare-Werehene, Meshach, et al.
Publicado: (2019)

Cisplatin-Resistant Gastric Cancer Cells Promote the Chemoresistance of Cisplatin-Sensitive Cells via the Exosomal RPS3-Mediated PI3K-Akt-Cofilin-1 Signaling Axis
por: Sun, Meng-Yao, et al.
Publicado: (2021)

Role of the RAB7 Protein in Tumor Progression and Cisplatin Chemoresistance
por: Guerra, Flora, et al.
Publicado: (2019)

Role of Metastasis-Related Genes in Cisplatin Chemoresistance in Gastric Cancer
por: Nishiguchi, Yukiko, et al.
Publicado: (2019)

Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy
por: Kryczka, Jolanta, et al.
Publicado: (2021)

Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy
por: Ma, Yuzhu, et al.
Publicado: (2019)

LncRNA MIR155HG Overexpression Promotes Proliferation, Migration, and Chemoresistance in Gastric Cancer Cells
por: Lin, Hong, et al.
Publicado: (2023)

Modulation of Calretinin Expression in Human Mesothelioma Cells Reveals the Implication of the FAK and Wnt Signaling Pathways in Conferring Chemoresistance towards Cisplatin
por: Wörthmüller, Janine, et al.
Publicado: (2019)

MiR‐192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF‐κB pathway
por: Li, Yang, et al.
Publicado: (2021)

Exosomes secreted by chemoresistant ovarian cancer cells promote angiogenesis
por: Li, Zhang, et al.
Publicado: (2021)

Potential roles of exosome non-coding RNAs in cancer chemoresistance
por: Wang, Yueyue, et al.
Publicado: (2021)

Circulating exosomal circFoxp1 confers cisplatin resistance in epithelial ovarian cancer cells
por: Luo, Yanwei, et al.
Publicado: (2020)

Downregulation of CPT2 promotes tumorigenesis and chemoresistance to cisplatin in hepatocellular carcinoma
por: Lin, Meihua, et al.
Publicado: (2018)

Cisplatin-Induced Giant Cells Formation Is Involved in Chemoresistance of Melanoma Cells
por: Weng, Chien-Hui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n63bi0ii1s5jun5k706u6tkca9